Skip to search formSkip to main contentSkip to account menu

Econor

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

valnemulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
VALNEMULIN - FOR THE PREVENTION AND TREATMENT OF COLITIS AND ILEITIS
Summary Valnemulin (Econor – Novartis) was approved originally in 1999 by the European Union (EU) for the prevention and… 
2002
2002
Aplicación terapéutica de Econor 1% en pienso ante diarreas en cebo
2001
2001
Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic.
Patients with primary antibody deficiency (PAD) are prone to mycoplasma infection with unusual strains which may be resistant to… 
2001
2001
Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics.
The authors have performed a comparative study of the efficacy of various in-feed medications for the treatment of 5- to 6-week… 
2000
2000
The application of predictive models in the environmental risk assessment of ECONOR.
2000
2000
A comparison of a new compound valnemulin (Econor® - Novartis) and tiamulin administered in-feed for the prevention and treatment of experimentally induced swine dysentery.
Highly Cited
1997
Highly Cited
1997
In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)